Novo Nordisk flags drug trial promise amid hunt for next weight-loss blockbuster

Thread starter International: Top News And Analysis
Start date Tuesday at 3:27 PM

International: Top News And Analysis

Guest

Tuesday at 3:27 PM

Phase 3 trial results showed the once-weekly Cagrilintide monotherapy injection helped patients reduce their weight by 11.8% on average after 68 weeks.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Novo Nordisk flags drug trial promise amid hunt for next weight-loss blockbuster

Prefix: N/A

Forum: World News

Start date: Tuesday at 3:27 PM

Last reply date: Tuesday at 3:27 PM

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Tuesday at 3:27 PM

Replies: 0

Views: 5

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search